High-dose dietary myo-inositol supplementation does not alter the ischaemia phenomenon in human diabetics.
Five diabetic patients and 3 non-diabetics were subjected to a dietary supplement of 20 g per day of myo-inositol (40 X the normal ingestion) for 14 days. This amount neither produced toxic side-effects nor changed the peripheral nervefunction expressed by motor conduction velocity or resistance to ischaemia.
Arendrup
K
K
Department of Endocrinology, Ribe County Hospital, Esbjerg, Denmark.
Gregersen
G
G
Hawley
J
J
Hawthorne
J N
JN
D000293:Adolescent; D000328:Adult; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000178:diet therapy*; D003929:Diabetic Neuropathies / Q000188:drug therapy* / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007294:Inositol / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008875:Middle Aged
D007294:Inositol